首页> 外文期刊>Australian journal of medical herbalism >Clinical study to evaluate the efficacy of a compound Unani herbal formulation Sharbat-e Unsul Murakkab in Sual-e-Muzmin (chronic bronchitis)
【24h】

Clinical study to evaluate the efficacy of a compound Unani herbal formulation Sharbat-e Unsul Murakkab in Sual-e-Muzmin (chronic bronchitis)

机译:评估复方Unani草药制剂Sharbat-e Unsul Murakkab在Sual-e-Muzmin(慢性支气管炎)中疗效的临床研究

获取原文
获取原文并翻译 | 示例
           

摘要

The present clinical study was undertaken as a single blindplacebo controlled study to determine the efficacy of the test drug in the treatment of chronic bronchitis as there is no curative treatmentavailable for chronic bronchitis in modern medicine. Unani compoundformulation i.e. Sharbat-e-Unsul Murakkab and placebo were given in the two groups of 20 diagnosed patients in each, of chronic bronchitis during winter cough in Unani OPD Majeedia Hospital, New Delhi. Theclinical, hematological and biochemical changes were observedand recorded accordingly. The response in patients of acute exacerbation ofchronic bronchitis, using a patient directed diary card incorporating sputum characteristics and symptoms were assessed. The study revealed that the test drug is safe and significantly reduced thesigns and symptoms of chronic bronchitis in comparison to placebo i.e. cough, sleep disturbance, sputum purulence, volume, viscosity, Rhonchi, Dyspnoea, and PEFT.
机译:本临床研究是作为一项单盲安慰剂对照研究进行的,目的是确定试验药物在治疗慢性支气管炎中的功效,因为现代医学中尚无治疗慢性支气管炎的有效方法。在新德里的Unani OPD Majeedia医院,在冬季咳嗽期间,在两组确诊为慢性支气管炎的两组患者中,分别给予20组确诊为慢性支气管炎的Unani复合制剂,即Sharbat-e-Unsul Murakkab和安慰剂。观察并记录临床,血液和生化变化。使用包含痰液特征和症状的患者指导日记卡评估了慢性支气管炎急性加重患者的反应。该研究表明,与安慰剂相比,该测试药物是安全的,并且可以显着减少慢性支气管炎的体征和症状,例如咳嗽,睡眠障碍,痰性化脓,容量,粘度,Ronchi,呼吸困难和PEFT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号